학술논문 – 부산대학교 도서관

학술논문

replay검색결과 돌아가기

search검색화면

The mTOR inhibitor Temsirolimus added to Rituximab combined with Dexamethasone, Cytarabine, and Cisplatinum (R-DHAP) for the treatment of patients with relapsed or refractory DLBCL – results from the phase-II storm trial

Document Type

Article

Author

Witzens-Harig, M.; Klemmer, J.; Geueke, A.-M.; Meißner, J.; Ho, A.D.; Viardot, A.; Keller, U.; Wosniok, J.; Deuster, O.; Atta, J.; Marks, R.; Rosée, P.L.; Buske, C.; Dreyling, M.H.; Hess, G.

Source

In: HemaSphere. (HemaSphere, 2021)

Subject

Language

English

ISSN

25729241

Online Access

Full Text (LWW Journals - Ovid) Full Text (LWW total - Ovid) Open Access (Wiley) Web of Science Scopus Find it@PNU

이메일